Hundreds of Feinberg faculty, fellows, residents, students and research staff presented their work at the 11th Annual Lewis Landsberg Research Day.
Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM) when delivered using spherical nucleic acid nanoparticles.
A new Northwestern Medicine study reveals that white matter loss is associated with impaired verbal abilities, an important implication for cognitive recovery following traumatic brain injury.
Northwestern Medicine scientists have created and transplanted an artificial ovarian system that induced puberty in mouse models, a first step toward a new approach to improving fertility in childhood cancer survivors.
Northwestern Medicine scientists used “big data” tools to classify for the first time three distinct categories of a common heart failure syndrome. The findings may be used to better predict how diverse patients will respond to treatments.
Xunrong Luo, MD, PhD, associate professor in Medicine-Nephrology, Microbiology-Immunology and Surgery-Organ Transplantation, has been selected to receive the American Society of Transplantation Basic Science Investigator Award.
Chad Mirkin, PhD, and colleagues show that spherical nucleic acids can be used to regulate immune responses in a new study that could shift the way scientists think about developing therapeutic agents for many diseases.
Northwestern Medicine scientists have identified mechanisms behind desmosomes, important junctions that bind cells together, helping to explain how some skin and heart diseases develop.
Feinberg is one of the nation’s top 20 medical schools in the annual U.S. News & World Report rankings, with women’s health, internal medicine and pediatrics positioned highly in medical specialty rankings.
A Northwestern Medicine study found that standard treatments for metastatic melanoma are not effective against Nodal, a growth factor protein critical for the skin cancer’s development, but also showed that combination therapies incorporating anti-Nodal antibodies are a promising alternative.